Sideinnhold
Følgende generelle metoder er opptatt i Ph. Eur. pr. 1. juli 2020
Nye tekster
| 2.6.37. | Principles for the detection of extraneous viruses in immunological veterinary medicinal products using culture methods |
|---|
Reviderte tekster
| 2.6.16. | Tests for extraneous agents in viral vaccines for human use |
|---|
| 4. | Reagents (new, revised, corrected) |
|---|
| 5.2.4. | Cell cultures for the production of vaccines for veterinary use |
|---|
| 5.2.5. | Management of extraneous agents in immunological veterinary medicinal products |
|---|
| 5.2.13. | Healthy chicken flocks for the production of inactivated vaccines for veterinary use |
|---|
Følgende generelle metoder var opptatt i Ph. Eur. pr. 1. april 2020
Reviderte tekster
| 2.4.24. | Identification and control of residual solvents |
|---|
| 4. | Reagents |
|---|
| 5.22. | Names of herbal drugs used in traditional Chinese medicine |
|---|
Følgende generelle metoder var opptatt i Ph. Eur. pr. 1. januar 2020
Nye tekster
| 2.6.35. | Quantification and characterisation of residual host-cell DNA |
|---|
| 2.9.49. | Powder flow properties by shear cell methods |
|---|
| 2.9.52. | Scanning electron microscopy |
|---|
| 3.3. | Containers for human blood and blood components, and materials used in their manufacture; transfusion sets and materials used in their manufacture; syringes |
|---|
| 5.25. | Process analytical technology |
|---|
Reviderte tekster
| 2.2.25. | Absorption spectrophotometry, ultraviolet and visible |
|---|
| 2.6.8. | Pyrogens |
|---|
| 2.6.33. | Residual pertussis toxin |
|---|
| 2.7.2. | Microbiological assay of antibiotics |
|---|
| 2.7.23. | Numeration of CD34/CD45+ cells in haematopoietic products |
|---|
| 2.7.35. | Immunonephelometry for vaccine component assay |
|---|
| 2.8.25. | High-performance thin-layer chromatography of herbal drugs and herbal drug preparations |
|---|
| 2.9.1. | Disintegration of tablets and capsules |
|---|
| 2.9.20. | Particulate contamination: visible particles |
|---|
| 3.1.13. | Plastic additives |
|---|
| 3.3.1. | Materials for containers for human blood and blood components |
|---|
| 3.3.2. | Materials based on plasticised poly(vinyl chloride) for containers for human blood and blood components |
|---|
| 3.3.3. | Materials based on plasticised poly(vinyl chloride) for tubing used in sets for the transfusion of blood and blood components |
|---|
| 3.3.4. | Sterile plastic containers for human blood and blood components |
|---|
| 3.3.5. | Empty sterile containers of plasticised poly(vinyl chloride) for human blood and blood components |
|---|
| 3.3.6. | Sterile containers of plasticised poly(vinyl chloride) for human blood containing anticoagulant solution |
|---|
| 3.3.7. | Sets for the transfusion of blood and blood components |
|---|
| 3.3.8. | Sterile single-use plastic syringes 4. Reagents |
|---|
| 5.3. | Statistical analysis of results of biological assays and tests |
|---|
| 5.8. | Pharmacopoeial harmonisation |
|---|
| 5.21. | Chemometric methods applied to analytical data |
|---|
| 5.22. | Names of herbal drugs used in traditional Chinese medicine |
|---|
| 5.24. | Chemical imaging |
|---|
